Idogen AB
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment wi… Read more
Market Cap & Net Worth: Idogen AB (IDOGEN)
Idogen AB (ST:IDOGEN) has a market capitalization of $1.12 Million (Skr12.58 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #36197 globally and #583 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Idogen AB's stock price Skr0.12 by its total outstanding shares 104374000 (104.37 Million).
Idogen AB Market Cap History: 2020 to 2025
Idogen AB's market capitalization history from 2020 to 2025. Data shows change from $28.38 Million to $1.12 Million (-56.94% CAGR).
Idogen AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Idogen AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IDOGEN by Market Capitalization
Companies near Idogen AB in the global market cap rankings as of March 18, 2026.
Key companies related to Idogen AB by market ranking:
- Peptron Inc (KQ:087010): Ranked #3322 globally with a market cap of $3.92 Billion USD ( ₩5.74 Trillion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #15247 globally with a market cap of $192.41 Million USD ( ₩281.72 Billion KRW).
- Bioneer Corporation (KQ:064550): Ranked #15689 globally with a market cap of $175.97 Million USD ( ₩257.66 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #18272 globally with a market cap of $99.40 Million USD ( ₩145.55 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3322 | Peptron Inc | KQ:087010 | $3.92 Billion | ₩311000.00 |
| #15247 | MEDIPOST Co. Ltd | KQ:078160 | $192.41 Million | ₩22200.00 |
| #15689 | Bioneer Corporation | KQ:064550 | $175.97 Million | ₩12100.00 |
| #18272 | Macrogen Inc | KQ:038290 | $99.40 Million | ₩16410.00 |
Idogen AB Historical Marketcap From 2020 to 2025
Between 2020 and today, Idogen AB's market cap moved from $28.38 Million to $ 1.12 Million, with a yearly change of -56.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr1.12 Million | 0.00% |
| 2024 | Skr1.12 Million | 0.00% |
| 2023 | Skr1.12 Million | -31.14% |
| 2022 | Skr1.63 Million | -86.76% |
| 2021 | Skr12.30 Million | -56.66% |
| 2020 | Skr28.38 Million | -- |
End of Day Market Cap According to Different Sources
On Jan 30th, 2026 the market cap of Idogen AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.12 Million USD |
| MoneyControl | $1.12 Million USD |
| MarketWatch | $1.12 Million USD |
| marketcap.company | $1.12 Million USD |
| Reuters | $1.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.